About: http://data.cimple.eu/news-article/7a2f30daeb92a129cf8b88befd623168021572aa6bdf4b73ca25c436

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/7a2f30daeb92a129cf8b88befd623168021572aa6bdf4b73ca25c436 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Brazil granted full regulatory approval Friday to the Covid-19 vaccine developed by Oxford University and pharmaceutical firm AstraZeneca, voicing confidence in it even as a raft of countries suspended its use. Federal health regulator Anvisa said it saw "no health risk for the population associated with the use of this vaccine," and upgraded it from emergency to full regulatory approval. "The benefits outweigh the risks," it said. The decision came despite the fact that countries including Denmark, Norway, Bulgaria and Thailand have suspended use of the vaccine as a precaution after reports of recipients developing blood clots. The European Medicines Agency said Friday severe allergies should be added to the vaccine's side effects warning. But the World Health Organization (WHO) insisted there was no reason to stop using it, describing it as an "excellent vaccine." AstraZeneca said there was no evidence of higher blood clot risks. Anvisa also approved the antiviral medication remdesivir for use against Covid-19, despite the WHO finding it has "little or no effect" on mortality from the disease. Hard-hit Brazil, which has struggled to source enough vaccines for its 212 million people, also announced the purchase of 10 million doses of Russia's Sputnik V. However, that vaccine still needs regulatory approval in the South American country, which is so far using only the Oxford vaccine and Chinese-developed CoronaVac. Both are two-dose vaccines. Around 9.3 million people have received a first dose of vaccine in Brazil, and around 3.3 million people a second. Covid-19 has claimed 273,000 lives in Brazil, according to health ministry figures, the second-highest death toll worldwide after the United States. jm/jhb/bfm
schema:headline	Brazil grants full approval to Oxford vaccine, orders Sputnik
schema:mentions	Thrombosis Bulgaria European Medicines Agency Antiviral drug Remdesivir Medication Sputnik 1 National Sanitary Surveillance Agency Mortality rate Allergy University of Oxford Denmark Norway World Health Organization Thailand AstraZeneca Russia Brazil Vaccine United States Coronavirus disease 2019 Venous thrombosis Radio in New Zealand
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-03-12 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	75 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness
http://data.cimple...entionsConspiracy	antivax conspiracy theory

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software